Medication info
Canarb Tablets 30mg (Pimasartan Potassium Hydrate)

Canarb Tablets 30mg (Pimasartan Potassium Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Fimasartan Potassium Trihydrate›33.005mg / 1 tablet
Manufacturer / importer
Boryung Pharmaceutical Co., Ltd.
Appearance
Green hexagonal biconvex film-coated tablet with rounded corners
Packaging
Domestic use - 30 tablets/bottle, Domestic use - 300 tablets/bottle, Export use - 10 tablets/box [(10 tablets/PTP x 1)], Export use - 30 tablets/box [(10 tablets/PTP x 3)]
Approval status
Active

MFDS item code 201207542 · Approved 2012.10.30 · Insurance code 641905940

Summary

Main use
Treatment of essential hypertension and relief of proteinuria in chronic kidney disease associated with type 2 diabetes and hypertension
Who takes it
Adults · Children
Adult dose
1. Essential hypertension Adults: The recommended dose of this medicine is 30 ~ 60 milligrams once daily, with or without food. If blood pressure is not adequately controlled at this dose, it may be increased to 120 milligrams once daily. If possible, it is recommended to take the medicine at the same time each day (e.g., in the morning). The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum effect at approximately 8 weeks ~ 12 weeks. No initial dose adjustment is required for elderly patients 70 years of age or younger. For elderly patients over 70 years of age, an initial dose of 30 mg once daily of this medicine is recommended. No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated at 30 milligrams once daily and should not exceed 60 milligrams once daily. No dose adjustment is required in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment. For patients at high risk of hypotension, such as those with reduced effective intravascular volume, an initial dose of 30 milligrams once daily is recommended. 2. Reduction of proteinuria in patients with hypertension and type 2 diabetic chronic kidney disease, as a treatment for hypertension Usually, this medicine is administered at 60 milligrams once daily, with or without food. Depending on blood pressure, the dose may be increased to 120 milligrams once daily. However, an initial dose of 30 milligrams is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with antidiabetic agents.
Child dose
Pediatric and adolescent patients 18 years of age or younger: Safety and efficacy have not been established.

Ingredients

Manufacturer
Boryung Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and relief of proteinuria in chronic kidney disease associated with type 2 diabetes and hypertension

  • Essential hypertension
  • hypertension
  • type 2 diabetic chronic kidney disease
  • proteinuria
View approved original text

This medicine is used to treat essential hypertension and is particularly effective in reducing proteinuria in patients with hypertension and type 2 diabetic chronic kidney disease. Therefore, it helps in blood pressure management as well as in protecting kidney function. This drug also contributes to preventing various complications associated with hypertension, improving the overall health of the patient.

How to take

Adult dose

1. Essential hypertension Adults: The recommended dose of this medicine is 30 ~ 60 milligrams once daily, with or without food. If blood pressure is not adequately controlled at this dose, it may be increased to 120 milligrams once daily. If possible, it is recommended to take the medicine at the same time each day (e.g., in the morning). The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum effect at approximately 8 weeks ~ 12 weeks. No initial dose adjustment is required for elderly patients 70 years of age or younger. For elderly patients over 70 years of age, an initial dose of 30 mg once daily of this medicine is recommended. No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated at 30 milligrams once daily and should not exceed 60 milligrams once daily. No dose adjustment is required in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment. For patients at high risk of hypotension, such as those with reduced effective intravascular volume, an initial dose of 30 milligrams once daily is recommended. 2. Reduction of proteinuria in patients with hypertension and type 2 diabetic chronic kidney disease, as a treatment for hypertension Usually, this medicine is administered at 60 milligrams once daily, with or without food. Depending on blood pressure, the dose may be increased to 120 milligrams once daily. However, an initial dose of 30 milligrams is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with antidiabetic agents.

Child dose

Pediatric and adolescent patients 18 years of age or younger: Safety and efficacy have not been established.

Precautions

This drug can cause serious harm to the fetus and newborn, especially when taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Patients who are allergic to any of the components in this drug, undergoing kidney dialysis, have severe liver impairment, or have bile duct obstruction should not take this medication. Patients with decreased blood volume or salt deficiency, impaired kidney function, or renovascular hypertension should exercise caution when taking this medication, and their condition should be closely monitored when starting or increasing the dosage. This medication can cause various side effects such as headaches, dizziness, dyspepsia, muscle pain, and skin rashes, so if any symptoms appear, consultation with a healthcare professional is necessary. Hypotension or electrolyte imbalances may occur, so especially if taking diuretics or having low salt intake, blood pressure and electrolyte status should be checked periodically. Due to the risk of increased potassium levels, patients with heart disease or kidney disease should have their serum potassium levels monitored regularly. When taken with other antihypertensives, potassium-sparing diuretics, lithium preparations, or non-steroidal anti-inflammatory drugs, precautions are necessary due to increased risk of side effects from interactions. During pregnancy, there is a risk of decreased fetal kidney function, decreased amniotic fluid, and malformations, so those planning or currently pregnant should consult a healthcare provider. Breastfeeding women are advised to either discontinue breastfeeding or the medication as this drug may be excreted into breast milk. In children under 18, safety and efficacy have not been established, so use should be avoided. In elderly patients, while the concentration of the drug in the body may increase, dosage adjustment is generally not necessary, but caution should be exercised based on their condition. Patients with moderate to severe liver impairment should avoid taking this drug, and it is important to check liver function status. In cases of overdose, symptoms such as hypotension or arrhythmia may occur, so immediate notification of a healthcare provider is necessary for appropriate treatment. This medication should be kept out of reach of children, and care should be taken as transferring it to another container can adversely affect its quality.

Side effects

  • Headache
  • dizziness
  • fainting
  • sedation
  • migraine
  • dyspepsia
  • vomiting
  • nausea
  • abdominal pain
  • weakness
Show 109 more
  • foreign body sensation
  • elevated liver enzyme levels
  • reduced platelet count
  • increased serum creatine phosphokinase
  • cough
  • muscle contraction
  • musculoskeletal rigidity
  • itching
  • localized urticaria
  • facial flushing
  • flushing
  • erectile dysfunction
  • epilepsy
  • amyotrophic lateral sclerosis
  • neuropathy
  • neuronitis
  • facial paralysis
  • normal pressure hydrocephalus
  • spinal stenosis
  • acute pancreatitis
  • bowel obstruction
  • hemorrhagic duodenal ulcer
  • appendicitis
  • hemorrhoids
  • abdominal pain
  • intracranial hemorrhage
  • transient ischemic attack
  • atherosclerosis
  • worsening cerebral infarction
  • cerebral hemorrhage
  • liver cancer
  • colorectal carcinoma
  • neoplasm of unspecified nature
  • cervical cancer
  • prostate cancer
  • acute renal failure
  • chronic renal failure
  • kidney stones
  • pyelonephritis
  • urinary incontinence
  • rhinitis
  • fibrosing alveolitis
  • pharyngitis
  • pneumonia
  • lung disease
  • death
  • worsening back pain
  • osteoarthritis
  • arthropathy
  • hypoglycemia
  • hyperkalemia
  • pulmonary embolism
  • purpura
  • bradycardia
  • atrial fibrillation
  • coronary artery disease
  • aortic stenosis
  • heart failure
  • elevated blood pressure
  • acute hepatitis
  • benign pituitary neoplasm
  • otitis media
  • uterine prolapse
  • recurrent cancer
  • fracture
  • chest pain
  • back pain
  • edema
  • limb pain
  • peripheral edema
  • facial edema
  • fatigue
  • fever
  • neck/shoulder pain
  • myalgia
  • pharyngitis
  • upper respiratory infection
  • sputum
  • rhinitis
  • nosebleed
  • bronchitis
  • sensory disturbances
  • numbness
  • tremor
  • hypertonia
  • insomnia
  • depression
  • anxiety
  • memory impairment
  • loss of appetite
  • gastroesophageal reflux
  • gastritis
  • diarrhea
  • constipation
  • functional bowel disease
  • gastroenteritis
  • frequent urination
  • urinary incontinence
  • kidney stones
  • dysuria
  • hyperlipidemia
  • dyslipidemia
  • hypoglycemia
  • cerebral infarction
  • herpes zoster
  • visual disturbances
  • tachycardia
  • purpura
  • fatty liver

Not everyone experiences these, and they can vary from person to person.

Storage

This drug is sensitive to light, so it should be stored in a tightly closed container that is light-blocking. Additionally, to maintain the drug's effectiveness, it should be stored at room temperature, that is between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Green hexagonal biconvex film-coated tablet with rounded corners

Package unit

Domestic use - 30 tablets/bottle, Domestic use - 300 tablets/bottle, Export use - 10 tablets/box [(10 tablets/PTP x 1)], Export use - 30 tablets/box [(10 tablets/PTP x 3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.